6Gottesman MM, Pastan I. Biochemistry of multi- drug resistance mediated by the multidrug trans- porter[J]. Annu Rev Biochem, 1993, 62: 385- 427.
7Solon EG, Balani SK, Luo G, et al. Interaction of ritonavir on tissue distribution of a [(14) c] L-vali- namide, a potent human immunodeficiency virus-1 protease inhibitor, in rats using quantitative whole- body autoradiography [ J ]. Drug Metab Dispos, 2002,30(11): 1164--1169.
8Drewe J, Gutmann H, Fricker G, et al. HIV prote- ase inhibitor ritonavir: a more potent inhibitor of P- glycoprotein than the cyclosporine analog SDZ PSC 833[J]. Biochem Pharmaeol,1999, 57(10) : 1147-- 1152.
9Shaik N, Pan G, Elmquist WF, et al. Interactions of pluronic block copolymers on P-gp efflux activi- ty: experience with HIV-1 protease inhibitors[J]. J Pharm Sci,2008,97(12) : 5421--5433.
10Kaddoumi A, Choi SU, Kinman L, et al. Inhibition of P-glycoprotein activity at the primate blood-brain barrier increases the distribution of nelfinavir into the brain but not into the cerebrospinal fluid[J]. Drug Metab Dispos,2007, 35(9) :1459--1462.
